Achieve Life Sciences, Inc.
ACHV
$2.92
-$0.06-2.01%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.85% | -3.78% | 1.21% | -47.88% | -30.29% |
| Total Depreciation and Amortization | -11.29% | 6.90% | 1.75% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -200.00% | 0.00% | 55.56% | -- | -- |
| Total Other Non-Cash Items | 29.70% | 37.21% | -11.04% | -3.79% | 8.74% |
| Change in Net Operating Assets | 190.15% | -146.94% | 722.22% | -88.64% | 324.63% |
| Cash from Operations | 18.21% | -20.67% | 11.41% | -110.77% | 6.94% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -40.96% | -3.11% | -11.71% | 128.50% | -- |
| Cash from Investing | -40.96% | -3.11% | -11.71% | 128.50% | -- |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | -- | -- |
| Issuance of Common Stock | -- | -- | 272.68% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 108.41% | -5,201.96% | -100.27% |
| Foreign Exchange rate Adjustments | 200.00% | -100.00% | -200.00% | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14,674.90% | -91.80% | 161.57% | 89.91% | -201.61% |